{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:06:35Z","timestamp":1791389195845,"version":"4.3.3"},"reference-count":88,"publisher":"Rockefeller University Press","issue":"1","license":[{"start":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:00:00Z","timestamp":1765843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,5]]},"abstract":"<jats:p>Infections are a significant cause of morbidity and mortality in inborn errors of immunity (IEI). Prevention of infections relies on knowledge of the specific pathogen susceptibility of the IEI to then consider antimicrobial prophylaxis, immune modulation, and\/or environmental measures. In addition, complications of IEI include bronchiectasis, which can lead to more infections due to disruption of mucociliary clearance; suppression of chronic infections and airway clearance measures are important parts of bronchiectasis management. We discuss some infections that are challenging to diagnose for patients with distinct IEI and how partnership with the microbiology laboratory can lead to more prompt diagnosis and specific management. Finally, the increasing ability to identify the molecular basis of IEI facilitates precise immunomodulation, which can attenuate the infection burden of these diseases yet can also add unique infection risks depending on the specific therapy.<\/jats:p>","DOI":"10.70962\/jhi.20250137","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T07:21:47Z","timestamp":1764055307000},"update-policy":"https:\/\/doi.org\/10.70962\/jhi.crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["How I Treat: Infections and inborn errors of immunity\u2014Prevention, diagnosis, and treatment"],"prefix":"10.70962","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7005-8345","authenticated-orcid":true,"given":"Alexandra F.","family":"Freeman","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"publisher"}],"name":"Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health 1 , Bethesda, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5922-0241","authenticated-orcid":true,"given":"Beth K.","family":"Thielen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/017zqws13","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Minnesota Medical School 2 Division of Pediatric Infectious Diseases, Department of Pediatrics, , Minneapolis, MN,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0763-8763","authenticated-orcid":true,"given":"Tamara C.","family":"Pozos","sequence":"additional","affiliation":[{"name":"University of Minnesota Medical School 3 Department of Clinical Immunology, Children\u2019s Minnesota, Department of Pediatrics, , Minneapolis, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2025,12,16]]},"reference":[{"key":"2025121609175948200_bib1","doi-asserted-by":"publisher","DOI":"10.70962\/jhi.20250003","article-title":"Human inborn errors of immunity: 2024 update on the classification from the international union of immunological societies expert committee","volume":"1","author":"Poli","year":"2025","journal-title":"J. Hum. Immunol."},{"key":"2025121609175948200_bib2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s10875-020-00865-9","article-title":"Infections in infants with SCID: Isolation, infection screening and prophylaxis in PIDTC centers","volume":"41","author":"Dorsey","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2025121609175948200_bib3","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"2025121609175948200_bib4","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1016\/j.jaip.2019.05.041","article-title":"The role of breast-feeding in cytomegalovirus transmission and hematopoietic stem cell transplant outcomes in infants with severe combined immunodeficiency","volume":"7","author":"Kelty","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025121609175948200_bib5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/infdis\/162.3.723","article-title":"Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease","volume":"162","author":"Margolis","year":"1990","journal-title":"J. Infect. Dis"},{"key":"2025121609175948200_bib6","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa021931","article-title":"Itraconazole to prevent fungal infections in chronic granulomatous disease","volume":"348","author":"Gallin","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"2025121609175948200_bib7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1006\/bcmd.1995.0028","article-title":"Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease","volume":"21","author":"Bemiller","year":"1995","journal-title":"Blood Cells. Mol. Dis."},{"key":"2025121609175948200_bib8","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jaip.2016.03.021","article-title":"A comprehensive approach to the management of children and adults with chronic granulomatous disease","volume":"4","author":"Thomsen","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"2025121609175948200_bib9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: Molecular, cellular, and clinical features from a French national survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Medicine"},{"key":"2025121609175948200_bib10","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s10875-021-01051-1","article-title":"STAT3 Hyper-IgE syndrome- an update and unanswered questions","volume":"41","author":"Tsilifis","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2025121609175948200_bib11","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jaip.2022.01.011","article-title":"Treatment of STAT3-deficient hyper-immunoglobulin E syndrome with monoclonal antibodies targeting allergic inflammation","volume":"10","author":"James","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"2025121609175948200_bib12","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.jaci.2015.07.003","article-title":"Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome","volume":"136","author":"Odio","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025121609175948200_bib13","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1086\/497373","article-title":"A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS clinical trials group study 323\/mycoses study group study 40","volume":"41","author":"Goldman","year":"2005","journal-title":"Clin. Infect Dis."},{"key":"2025121609175948200_bib14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin. Immunol."},{"key":"2025121609175948200_bib15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jaip.2013.09.013","article-title":"Antibiotic prophylaxis in primary immune deficiency disorders","volume":"1","author":"Kuruvilla","year":"2013","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"2025121609175948200_bib16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaci.2019.01.051","article-title":"Azithromycin improves lung function and reduces respiratory exacerbations in patients with primary antibody deficiencies and chronic lung disease: A randomized controlled trial","volume":"144","author":"Milito","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025121609175948200_bib17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s10875-020-00841-3","article-title":"Immunoglobulin replacement therapy versus antibiotic prophylaxis as treatment for incomplete primary antibody deficiency","volume":"41","author":"Smits","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2025121609175948200_bib18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ccm.2012.03.002","article-title":"Genetic causes of bronchiectasis","volume":"33","author":"Gould","year":"2012","journal-title":"Clin. Chest Med."},{"key":"2025121609175948200_bib19","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1164\/rccm.202407-1415OC","article-title":"STAT3-dependent regulation of CFTR and ciliogenesis is essential for mucociliary clearance and innate airway defense in hyper-IgE syndrome","volume":"211","author":"Sun","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2025121609175948200_bib20","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jaci.2022.12.821","article-title":"STAT3 mutation-associated airway epithelial defects in Job syndrome","volume":"152","author":"Zhang","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025121609175948200_bib21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1001\/jama.2025.2680","article-title":"Non-cystic fibrosis bronchiectasis in adults: A review","volume":"334","author":"Barker","year":"2025","journal-title":"JAMA"},{"key":"2025121609175948200_bib22","doi-asserted-by":"publisher","first-page":"e571","DOI":"10.7861\/clinmed.2021-0651","article-title":"Diagnosis and management of non-cystic fibrosis bronchiectasis","volume":"21","author":"Macfarlane","year":"2021","journal-title":"Clin. Med."},{"key":"2025121609175948200_bib23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/antibiotics14020165","article-title":"Utilization of inhaled antibiotics in pediatric non-cystic fibrosis bronchiectasis: A comprehensive review","volume":"14","author":"Tsouprou","year":"2025","journal-title":"Antibiotics"},{"key":"2025121609175948200_bib24","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1080\/14787210.2025.2530624","article-title":"Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?","volume":"23","author":"Ito","year":"2025","journal-title":"Expert Rev. Anti Infect Ther."},{"key":"2025121609175948200_bib25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2500\/aap.2024.45.240063","article-title":"Overview of secondary immunodeficiency","volume":"45","author":"Herman","year":"2024","journal-title":"Allergy Asthma Proc."},{"key":"2025121609175948200_bib26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/hematology.2020000116","article-title":"Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseases","volume":"2020","author":"Malpica","year":"2020","journal-title":"Hematol. ASH Education Program"},{"key":"2025121609175948200_bib27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1053\/j.gastro.2024.11.008","article-title":"AGA clinical practice guideline on the prevention and treatment of hepatitis B virus reactivation in at-risk individuals","volume":"168","author":"Ali","year":"2025","journal-title":"Gastroenterology"},{"key":"2025121609175948200_bib28","doi-asserted-by":"publisher","first-page":"ofaa080","DOI":"10.1093\/ofid\/ofaa080","article-title":"Assessing hepatitis B reactivation risk with rituximab and recent intravenous immunoglobluin","volume":"7","author":"Dysart","year":"2020","journal-title":"Open Forum Infect Dis."},{"key":"2025121609175948200_bib29","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1093\/cid\/civ1220","article-title":"Progressive multifocal leukoencephalopathy in primary immune deficiencies: STAT1 gain of function and review of the literature","volume":"15","author":"Zerbe","year":"2016","journal-title":"Clin. Infect Dis."},{"key":"2025121609175948200_bib30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1378\/chest.12-0477","article-title":"Pneumocystis pneumonia in patients treated with rituximab","volume":"144","author":"Martin-Garrido","year":"2013","journal-title":"Chest"},{"key":"2025121609175948200_bib31","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025121609175948200_bib32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jaci.2023.10.018","article-title":"JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: An ESID\/EBMT-IEWP retrospective study","volume":"153","author":"Fischer","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025121609175948200_bib33","doi-asserted-by":"publisher","first-page":"107143","DOI":"10.1016\/j.clineuro.2022.107143","article-title":"Tofacitinib-induced progressive multifocal leukoencephalopathy with immune reconstitution inflammatory syndrome","volume":"214","author":"Yun","year":"2022","journal-title":"Clin. Neurol. Neurosurg."},{"key":"2025121609175948200_bib34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10875-020-00901-8","article-title":"Infections in patients with chronic granulomatous disease treated with tumor necrosis factor alpha blockers for inflammatory complications","volume":"41","author":"Conrad","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2025121609175948200_bib35","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1086\/657308","article-title":"Complications of tumor necrosis factor-alpha blockade in chronic granulomatous disease- related colitis","volume":"51","author":"Uzel","year":"2010","journal-title":"Clin. Infect Dis."},{"key":"2025121609175948200_bib36","doi-asserted-by":"publisher","first-page":"1538453","DOI":"10.3389\/fimmu.2025.1538453","article-title":"Enhanced T-cell immunity and lower humoral responses following 5-dose SARS-CoV2 vaccination in patients with inborn errors of immunity compared with healthy controls","volume":"16","author":"Lopes da Silva","year":"2025","journal-title":"Front Immunol."},{"key":"2025121609175948200_bib37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11882-017-0749-3","article-title":"Influenza vaccination in patients with common variable immunodeficiency (CVID)","volume":"17","author":"Mieves","year":"2017","journal-title":"Curr. Allergy Asthma Rep."},{"key":"2025121609175948200_bib38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/acr.25045","article-title":"American college of rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases","volume":"75","author":"Bass","year":"2022","journal-title":"Arthritis Care Res."},{"key":"2025121609175948200_bib39","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1097\/ACI.0000000000000694","article-title":"Rubella virus- associated chronic inflammation in primary immunodeficiency diseases","volume":"20","author":"Perelygina","year":"2020","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"2025121609175948200_bib40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008080","article-title":"Infectious vaccine-derived rubella virus emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiency","volume":"15","author":"Perelygina","year":"2019","journal-title":"PloS Pathog."},{"key":"2025121609175948200_bib41","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1086\/520985","article-title":"Fulminant mulch pneumonitis: An emergency presentation of chronic granulomatous disease","volume":"45","author":"Siddiqui","year":"2007","journal-title":"Clin. Infect Dis"},{"key":"2025121609175948200_bib42","doi-asserted-by":"publisher","DOI":"10.1099\/jmmcr.0.005084","article-title":"Chromobacterium violaceum infection in chronic granulomatous disease: A case report and review of the literature","volume":"4","author":"Meher-Homji","year":"2017","journal-title":"JMM Case Rep."},{"key":"2025121609175948200_bib43","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s10875-016-0291-4","article-title":"Hyper IgM syndrome: A report from the USIDNET registry","volume":"36","author":"Leven","year":"2016","journal-title":"J. Clin. Immunol."},{"key":"2025121609175948200_bib44","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1097\/TP.0000000000002649","article-title":"Cryptospordium infection in dedicator of cytokinesis 8 (DOCK8) deficiency","volume":"8","author":"Yakov","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"2025121609175948200_bib45","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s10875-013-9890-5","article-title":"Lung parenchyma surgery in autosomal dominant Hyper IgE syndrome","volume":"33","author":"Freeman","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"2025121609175948200_bib46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0020028","article-title":"A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease","volume":"2","author":"Greenberg","year":"2006","journal-title":"PLoS Pathog."},{"key":"2025121609175948200_bib47","doi-asserted-by":"publisher","first-page":"807136","DOI":"10.3389\/fcimb.2021.807136","article-title":"Infections with enterohepatic non-H. pylori Helicobacter species in X-linked agammaglobulinemia: Clinical cases and review of the literature","volume":"11","author":"Romo-Gonzalez","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"2025121609175948200_bib48","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1007\/s10875-012-9750-8","article-title":"Successful approach to treatment of Helicobacter bilis infection in X-linked agammaglobulinemia","volume":"32","author":"Turvey","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"2025121609175948200_bib49","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0163-4453(96)92441-x","article-title":"Common variable immunodeficiency presenting as a Mycoplasma hominis septic arthritis","volume":"33","author":"Steuer","year":"1996","journal-title":"J. Infect"},{"key":"2025121609175948200_bib50","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jaip.2015.12.015","article-title":"Enteroviruses in X-linked agammaglobulinemia: Update on epidemiology and therapy","volume":"4","author":"Bearden","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"2025121609175948200_bib51","doi-asserted-by":"publisher","first-page":"106142","DOI":"10.1016\/j.jinf.2024.106142","article-title":"Novel antivirals for severe enterovirus infection in immunocompromised hosts: A case series","volume":"88","author":"Meinhardt","year":"2024","journal-title":"J. Infect"},{"key":"2025121609175948200_bib52","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/cei.12884","article-title":"Chronic norovirus infection and common variable immunodeficiency","volume":"188","author":"Woodward","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"2025121609175948200_bib53","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/infdis\/jiae398","article-title":"Reconstitution of norovirus-specific T-cell responses following hematopoietic stem cell transplantation in patients with inborn errors of immunity and chronic norovirus infection","volume":"231","author":"Durkee-Shock","year":"2025","journal-title":"J. Infect Dis."},{"key":"2025121609175948200_bib54","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10875-024-01756-z","article-title":"Rubella virus-associated granulomas controlled with allogeneic hematopoietic stem cell transplantation","volume":"44","author":"Hautala","year":"2024","journal-title":"J. Clin. Immunol."},{"key":"2025121609175948200_bib55","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jaad.2023.05.058","article-title":"Cutaneous granulomas associated with rubella virus: A clinical review","volume":"90","author":"Zhang","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"2025121609175948200_bib56","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s10875-018-0558-z","article-title":"Chronic Aichi virus infection in X-linked agammaglobulinemia","volume":"38","author":"Bucciol","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"2025121609175948200_bib57","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s10875-022-01410-6","article-title":"Aichivirus: An emerging pathogen in patients with primary and secondary B-cell deficiency","volume":"43","author":"Meyts","year":"2023","journal-title":"J. Clin. Immunol."},{"key":"2025121609175948200_bib58","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s10875-021-01056-w","article-title":"Hematopoietic stem cell transplantation cures chronic Aichi virus infection in X-linked agammaglobulinemia","volume":"41","author":"Bucciol","year":"2021","journal-title":"J. Clin. Immunol."},{"key":"2025121609175948200_bib59","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/imr.13290","article-title":"Rubella virus chronic inflammatory disease and other unusual viral phenotypes in inborn errors of immunity","volume":"322","author":"Kilich","year":"2024","journal-title":"Immunol. Rev."},{"key":"2025121609175948200_bib60","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3390\/jof9050554","article-title":"Genetic and other determinants for the severity of coccidioidomycosis: A clinician\u2019s perspective","volume":"9","author":"Galgiani","year":"2023","journal-title":"J. Fungi"},{"key":"2025121609175948200_bib61","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.clinthera.2019.08.011","article-title":"Host-pathogen interactions in coccidioidomycosis: Prognostic clues and opportunities for therapies","volume":"41","author":"Krogstad","year":"2019","journal-title":"Clin. Ther."},{"key":"2025121609175948200_bib62","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3201\/eid2302.160505","article-title":"Risk factors for disseminated Coccidioidomycosis, United States","volume":"23","author":"Odio","year":"2017","journal-title":"Emerg. Infect Dis."},{"key":"2025121609175948200_bib63","doi-asserted-by":"publisher","first-page":"ofaa167","DOI":"10.1093\/ofid\/ofaa167","article-title":"Coccidioidomycosis in patients treated with ruxolitinib","volume":"7","author":"Kusne","year":"2020","journal-title":"Open Forum Infect Dis."},{"key":"2025121609175948200_bib64","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.jaci.2015.07.003","article-title":"Endemic mycoses in patients with hyper-IgE (Job) syndrome","volume":"136","author":"Odio","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025121609175948200_bib65","doi-asserted-by":"publisher","first-page":"ciaf256","DOI":"10.1093\/cid\/ciaf256","article-title":"2025 clinical practice guideline update by the infectious diseases society of America on Histoplasmosis: Treatment of asymptomatic Histoplasma pulmonary nodules (Histoplasmosis) and mild or moderate acute pulmonary Histoplasmosis in adults, children, and pregnant people","author":"Arnold","year":"2025","journal-title":"Clin. Infect Dis."},{"key":"2025121609175948200_bib66","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.4049\/jimmunol.2200512","article-title":"Immunity to cryptosporidium: Lessons from acquired and primary immunodeficiencies","volume":"209","author":"Cohn","year":"2022","journal-title":"J. Immunol."},{"key":"2025121609175948200_bib67","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1097\/TP.0000000000002649","article-title":"Tandem orthotopic living donor liver transplantation followed by same donor haploidentical hematopoietic stem cell transplanation for DOCK8 deficiency","volume":"103","author":"Freeman","year":"2019","journal-title":"Transplantation"},{"key":"2025121609175948200_bib68","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/TP.0000000000002114","article-title":"Successful sequential liver and hematopoietic stem cell transplantation in a child with CD40 ligand deficiency and Cryptosporidium-induced liver cirrhosis","volume":"102","author":"Quarello","year":"2018","journal-title":"Transplantation"},{"key":"2025121609175948200_bib69","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1086\/514566","article-title":"Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: A randomized, double- blind, placebo-controlled multicenter trial","volume":"26","author":"Oldfield","year":"1998","journal-title":"Clin. Infect Dis."},{"key":"2025121609175948200_bib70","doi-asserted-by":"publisher","first-page":"1078976","DOI":"10.3389\/fimmu.2023.1078976","article-title":"Case report: Nontuberculous mycobacterial infections in children with complete DiGeorge anomaly","volume":"14","author":"Hicks","year":"2023","journal-title":"Front. Immunol."},{"key":"2025121609175948200_bib71","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1016\/j.jaip.2022.03.032","article-title":"BCG infection in patients with inborn errors of immunity receiving the Russian BCG strain","volume":"10","author":"Laberko","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025121609175948200_bib72","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaci.2021.11.016","article-title":"Anticytokine autoantibodies: Autoimmunity trespassing on antimicrobial immunity","volume":"149","author":"Cheng","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"2025121609175948200_bib73","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.4049\/jimmunol.1202526","article-title":"Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis","volume":"190","author":"Rosen","year":"2013","journal-title":"J. Immunol."},{"key":"2025121609175948200_bib74","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cid\/ciz786","article-title":"Natural history and evolution of anti-interferon autoantibody- associated immunodeficiency syndrome in Thailand and the United States","volume":"71","author":"Hong","year":"2020","journal-title":"Clin. Infect Dis."},{"key":"2025121609175948200_bib75","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against Type 1 IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"2025121609175948200_bib76","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202486","article-title":"Auto-antibodies to Type 1 IFNs can underlie adverse reactions to yellow fever life attenuated vaccine","volume":"218","author":"Bastard","year":"2021","journal-title":"J. Exp. Med."},{"key":"2025121609175948200_bib77","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20230661","article-title":"Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in 40% of patients","volume":"220","author":"Gervais","year":"2023","journal-title":"J. Exp. Med."},{"key":"2025121609175948200_bib78","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fonc.2014.00307","article-title":"Good syndrome, bad problem","volume":"4","author":"Martinez","year":"2014","journal-title":"Front. Oncol."},{"key":"2025121609175948200_bib79","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/INF.0b013e318218181d","article-title":"Corticosteroids in the treatment of severe nocardia pneumonia in chronic granulomatous disease","volume":"30","author":"Freeman","year":"2011","journal-title":"Pediatr. Infect Dis. J."},{"key":"2025121609175948200_bib80","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/cid\/cir896","article-title":"Corticosteroid therapy for liver abscess in chronic granulomatous disease","volume":"54","author":"Leiding","year":"2012","journal-title":"Clin. Infect Dis."},{"key":"2025121609175948200_bib81","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/0897190016646510","article-title":"Adrenal insufficiency with voriconazole and inhaled\/intranasal corticosteroids: Case report and systemic review","volume":"30","author":"Duman","year":"2017","journal-title":"J. Pharm. Pract."},{"key":"2025121609175948200_bib82","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jaad.2009.09.033","article-title":"Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole","volume":"62","author":"Cowen","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"2025121609175948200_bib83","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1080\/14740338.2024.2391492","article-title":"Voriconazole-induced central nervous system toxicity: A pharmacovigilance study based on FDA adverse event reporting system (FAERS)","volume":"23","author":"Yun","year":"2024","journal-title":"Expert Opin. Drug Saf."},{"key":"2025121609175948200_bib84","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2214\/AJR.18.19991","article-title":"Spectrum of voriconazole-induced periostitis with review of the differential diagnosis","volume":"212","author":"Tan","year":"2019","journal-title":"AJR Am. J. Roentgenol"},{"key":"2025121609175948200_bib85","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1093\/jac\/dkaa366","article-title":"Management of posaconazole-induced pseudohyperaldosteronism","volume":"75","author":"Davis","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"2025121609175948200_bib86","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1007\/s10875-020-00827-1","article-title":"Obstetric and gynecological care in patients with STAT3-deficeint Hyper IgE syndrome","volume":"40","author":"Parisi","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"2025121609175948200_bib87","doi-asserted-by":"publisher","DOI":"10.1172\/JCI164918","article-title":"A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome","volume":"133","author":"McDermott","year":"2023","journal-title":"J. Clin. Invest."},{"key":"2025121609175948200_bib88","doi-asserted-by":"publisher","first-page":"uxaf014","DOI":"10.1093\/cei\/uxaf014","article-title":"Unveiling WHIM syndrome: Mavorixafor\u2019s emerging role in immune restoration and therapy","volume":"219","author":"Khan","year":"2025","journal-title":"Clin. Exp. Immunol."}],"container-title":["Journal of Human Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jhi\/article-pdf\/doi\/10.70962\/jhi.20250137\/1955129\/jhi_20250137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jhi\/article-pdf\/doi\/10.70962\/jhi.20250137\/1955129\/jhi_20250137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T14:18:11Z","timestamp":1765894691000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jhi\/article\/2\/1\/e20250137\/278580\/How-I-Treat-Infections-and-inborn-errors-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,16]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,5]]}},"URL":"https:\/\/doi.org\/10.70962\/jhi.20250137","relation":{},"ISSN":["3065-8993"],"issn-type":[{"value":"3065-8993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,16]]},"article-number":"e20250137"}}